Creative Medical Technology Holdings, Inc. (CELZ) Stock Overview
Explore Creative Medical Technology Holdings, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Creative Medical Technology Holdings, Inc. (CELZ)
Key Financials
Key Financials
Market Cap
3.4M
P/E Ratio
-0.64
EPS (TTM)
$-2.14
ROE
-0.87%
CELZ Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Creative Medical Technology Holdings, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of CELZ on the NASDAQ shows an RSI of 59.06, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.
Key metrics behind Creative Medical Technology Holdings, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.64 and a market capitalization of 3.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CELZ on the NASDAQ.